Skye Bioscience (SKYE) Current Assets (2012 - 2026)
Skye Bioscience (SKYE) posted Current Assets of $10.96 million for Q2 2026, down 78.3% from $50.58 million a year earlier and down 41.0% from the prior quarter.
Skye Bioscience (SKYE) Current Assets (2012 - 2026) Analysis & Trends
At the end of FY2025, Skye Bioscience's Current Assets came in at $27.09 million, down 61.7% from FY2024.
- Annual Current Assets shows a five-year compound annual growth rate of 59.0% (FY2020 to FY2025).
- In prior years, Skye Bioscience's Current Assets was $70.83 million in FY2024 (+507.9%), $11.65 million in FY2023 (+30.3%), $8.94 million in FY2022 (-7.0%) and $9.61 million in FY2021 (+260.8%).
- The Q2 2026 figure stands as the lowest quarterly Current Assets since Q2 2023.
- On a year-over-year basis, Current Assets has declined in each of the last six quarters, with growth averaging 74.3% over the last eight quarters.
- The strongest year-over-year quarter for Current Assets in the past five years was Q4 2024, with growth of 507.9%; the weakest was Q2 2026, with a decline of 78.3%.
- According to Business Quant data, Current Assets for the three prior quarters was $18.57 million (Q1 2026), $27.09 million (Q4 2025) and $39.92 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn | 65.26 Bn |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn | 56.35 Bn |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn | 37.48 Bn |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn | 38.94 Bn |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - | - |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn | 31.45 Bn |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn | 34.36 Bn |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn | 16.55 Bn |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn | 45.01 Bn |
| 10 | Skye Bioscience | 5.38 Mn | -52.34 Mn | - | 5.04 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 5.04 Mn |
| Jun 30, 2026 | 10.96 Mn |
| Mar 31, 2026 | 18.57 Mn |
| Dec 31, 2025 | 27.09 Mn |
| Sep 30, 2025 | 39.92 Mn |
| Jun 30, 2025 | 50.58 Mn |
| Mar 31, 2025 | 63.03 Mn |
| Dec 31, 2024 | 70.83 Mn |
| Sep 30, 2024 | 79.81 Mn |
| Jun 30, 2024 | 87.00 Mn |
| Mar 31, 2024 | 94.57 Mn |
| Dec 31, 2023 | 11.65 Mn |
| Sep 30, 2023 | 15.29 Mn |
| Jun 30, 2023 | 1.89 Mn |
| Mar 31, 2023 | 4.45 Mn |
| Dec 31, 2022 | 8.94 Mn |
| Sep 30, 2022 | 2.68 Mn |
| Jun 30, 2022 | 4.77 Mn |
| Mar 31, 2022 | 6.99 Mn |
| Dec 31, 2021 | 9.61 Mn |
Skye Bioscience Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=SKYE&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "SKYE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=SKYE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();